Citalopram, the active ingredient of Celexa, is a selective serotonin reuptake inhibitor (SSRI) antidepressant used mainly for depression. It is prescribed for adults whose symptoms have been assessed clinically, and it may also help selected anxiety-spectrum or panic symptoms. By increasing serotonin signalling between nerve cells, Celexa can support gradual improvements in mood and daily functioning.
Celexa contains citalopram hydrobromide, also called Citalopram HBr. It belongs to the SSRI class of antidepressants.
Celexa contains citalopram hydrobromide, also called Citalopram HBr. It belongs to the SSRI class of antidepressants. The tablets are used primarily in the treatment of depression, including persistent low mood, loss of interest, reduced motivation, sleep disturbance and changes in appetite when these symptoms form part of a depressive illness.
Citalopram blocks the serotonin transporter, which normally removes serotonin from the space between nerve cells. This increases serotonin availability in relevant neural pathways. SSRIs do not act as general mood enhancers; they are prescribed for diagnosed or clinically assessed conditions in which their risk–benefit profile is appropriate.
A clinician considers the pattern and duration of symptoms, previous treatment, medical history, current medicines, alcohol or recreational substance use, bipolar symptoms and suicide risk before prescribing Celexa. The New Zealand product information and Medsafe safety guidance remain important references for treatment decisions.[1]
Depression can affect mood, concentration, sleep, appetite, energy and the ability to manage ordinary responsibilities. Celexa may improve several of these symptoms, but response differs between patients. A medicine that helped one depressive episode may not be the best choice for another.
Citalopram is not an emergency treatment for sudden distress. Its clinical effect develops gradually, while urgent suicidal thoughts, severe agitation or rapidly worsening symptoms require prompt medical attention.
The tablets are used primarily in the treatment of depression, including persistent low mood, loss of interest, reduced motivation, sleep disturbance and changes in appetite when these symptoms form part of a depressive illness.
Citalopram may be prescribed for selected anxiety-spectrum symptoms or panic attacks, depending on local approval, clinical judgement and patient history. Any benefit is preventive and gradual. Celexa does not stop an acute panic attack within minutes.
The regimen for the chosen strength is confirmed with a healthcare professional before starting. Celexa is taken by mouth, generally once daily, at a consistent time. The prescribed dose may be adjusted according to response, tolerability, age, liver function, other medicines and the clinical diagnosis.
Citalopram has a dose-related effect on the QT interval, an electrical measurement on an electrocardiogram. For that reason, higher doses are not automatically better, and some patients need a different medicine or cardiac monitoring.
If a dose is remembered fairly soon, the usual approach is to take it unless the next dose is close. If the next scheduled dose is near, skip the missed dose and resume the normal timetable. Taking two doses together can increase adverse effects and does not restore treatment progress safely.
Stopping suddenly may cause dizziness, nausea, irritability, vivid dreams, sleep disturbance, electric-shock sensations or flu-like feelings. A prescriber-led taper reduces the risk of discontinuation symptoms. The taper may be slower after long-term treatment or when symptoms return easily.
Celexa is not suitable for everyone. Treatment requires a careful clinical plan when the patient has heart disease, a history of irregular heartbeat, liver disease, kidney disease, glaucoma, a bleeding disorder, seizure history or bipolar disorder.
Celexa is not for you if you have a known serious allergy to citalopram, are taking an incompatible MAOI, or have a medical condition that makes the prescriber judge its cardiac or interaction risks unacceptable.
Pregnancy, breastfeeding, seizure history and suicidal thoughts also require specific discussion before treatment begins.
Tell the prescriber about fainting, unexplained palpitations, congenital long-QT syndrome, previous rhythm problems or medicines that affect the QT interval. Glaucoma history also needs disclosure, especially if eye pain, halos around lights, sudden blurred vision, redness or severe headache occurs.
Liver disease can slow citalopram clearance and may require a lower dose or closer review. Bleeding disorders, anticoagulants, antiplatelet medicines and anti-inflammatory pain medicines should be discussed before treatment.
A history of bipolar disorder must be disclosed. Antidepressant treatment can trigger excessive energy, reduced need for sleep, racing thoughts, impulsive behaviour or an unusually elevated mood in susceptible patients.
The most frequently discussed treatment effects include nausea, dry mouth, sweating, tremor, headache, sleep changes, tiredness and sexual side effects. Some people experience reduced libido, delayed orgasm or difficulty reaching orgasm. These effects may continue after mood has improved and deserve a direct conversation with the prescriber.
A practical point is easy to miss: improved mood does not always remove sexual side effects. A treatment review can consider dose timing, dose adjustment or another clinically suitable option.
Serotonin syndrome is a potentially life-threatening reaction caused by excessive serotonergic activity. Warning signs include agitation, confusion, fever, sweating, shivering, diarrhoea, muscle rigidity, marked tremor, rapid heartbeat and loss of coordination.
The risk rises after adding a serotonergic medicine, increasing a dose or combining medicines with overlapping effects. Urgent medical help is required, especially when symptoms develop quickly or several symptoms occur together. Do not wait for a routine appointment.
Seek urgent medical help for swelling of the lips, tongue or throat, breathing difficulty, widespread blistering rash or faintness after taking citalopram. An allergic reaction is different from ordinary nausea or a mild headache.
Palpitations, fainting, seizure, severe dizziness or a new irregular heartbeat can signal a serious cardiac or neurological problem. Citalopram can also increase bleeding risk, especially when combined with anticoagulants, antiplatelet medicines or some anti-inflammatory pain medicines.
Citalopram increases the amount of serotonin available for signalling between nerve cells. Serotonin is a neurotransmitter, meaning a chemical messenger used by the nervous system. It participates in circuits involved in mood, anxiety, sleep, appetite, pain processing and sexual function.
After serotonin is released, a transporter normally moves some of it back into the nerve cell. Citalopram inhibits this reuptake process. The biochemical effect begins before a patient necessarily feels better, because changes in brain signalling, sleep, motivation and emotional processing do not occur at the same speed.
Depression is not explained by a single serotonin level. Genetics, stress, inflammation, sleep, physical illness and psychological factors can all contribute. This is why treatment often combines medication review with psychological therapy, practical support and attention to sleep and alcohol use.
Common mistakes can reduce benefit or create avoidable risk:
Other antidepressants differ in mechanism, tolerability and monitoring needs. The choice depends on symptoms, previous response, medical conditions and interactions.
| Medicine or class | Clinical considerations and trade-offs |
|---|---|
| Escitalopram; sertraline | Closely related or alternative SSRIs. They may suit depression or anxiety, but can still cause nausea, sleep changes and sexual side effects. |
| Venlafaxine; SNRIs | Affect serotonin and noradrenaline. They may help some patients, while blood pressure, withdrawal symptoms and activation require attention. |
| Bupropion; mirtazapine | Bupropion may cause fewer sexual effects for some patients but can worsen anxiety or be unsuitable with seizure risk. Mirtazapine may cause sedation and increased appetite. |
Escitalopram is closely related to citalopram. Sertraline, venlafaxine, bupropion and mirtazapine have different pharmacological profiles. Switching requires a clinician-led plan because abrupt changes, overlap or unsuitable washout periods can cause withdrawal, toxicity or relapse.
A clinician considers the pattern and duration of symptoms, previous treatment, medical history, current medicines, alcohol or recreational substance use, bipolar symptoms and suicide risk before prescribing Celexa. The New Zealand product information and Medsafe safety guidance remain important references for treatment decisions.[1]
Reviews commonly assess mood, anxiety, sleep, work or study, relationships, side effects and suicidal thinking. Doctors often look for improved function rather than relying only on a numerical mood score.
Alcohol can increase dizziness, drowsiness, poor coordination and impaired judgement while using citalopram. It may also worsen sleep and depressive symptoms, even when no severe interaction occurs. The FDA's 2017 Celexa prescribing information advises caution with activities requiring alertness, and Medsafe's 2023 information supports reviewing alcohol use as part of treatment safety.[2]
Take the missed tablet when remembered unless the next scheduled dose is close. If the next dose is near, skip the forgotten dose and continue normally; do not take two doses together. The FDA's 2017 Celexa label describes this approach and warns against compensating with extra medication.
Arrange a treatment review if depression, anxiety or daily functioning does not improve as expected. The review may consider adherence, interactions, dose, diagnosis, bipolar symptoms, alcohol, sleep and psychological treatment. The 2022 NICE guidance on depression recommends reviewing response and functioning rather than assuming that a single medicine will suit every patient.[3]
Sudden stopping can cause dizziness, nausea, irritability, sleep disturbance, sensory changes and flu-like symptoms. A gradual taper is usually planned with the prescriber, with the speed adjusted to treatment duration, dose and previous withdrawal symptoms. The Royal College of Psychiatrists' 2020 guidance describes antidepressant withdrawal as a reason for planned reduction rather than abrupt cessation.[4]
Citalopram may cause dizziness, tiredness, sleep disturbance or reduced concentration, especially after starting or changing the dose. Do not drive or operate machinery until you know how the medicine affects you. The FDA's 2017 Celexa label warns that alcohol, Xanax, clonidine and other sedating substances can increase impairment.
Older adults may be more vulnerable to low sodium, falls, bleeding, heart-rhythm effects and medicine interactions. Liver function, kidney function, other prescriptions and cardiac history can influence the treatment plan. The American Geriatrics Society's 2023 Beers Criteria identifies citalopram as a medicine requiring caution in some older adults, with monitoring guided by the prescriber.[5]
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
The first week brought nausea and restless sleep. By the fourth week I was getting through work more reliably, although the improvement was gradual rather than dramatic.
My mood became steadier after a while, but reduced libido was difficult. I stopped wanting to deal with it, then learned that stopping suddenly was a bad idea and arranged a review instead.
I nearly took two tablets together. The medication instructions from my prescriber helped me resume the usual schedule, and I started using a reminder so it happened less often.
